Article info

Communication
Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why?

Authors

  • Dan Chaltiel Bureau de Biostatistique et d’Épidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France Oncostat U1018, Inserm, Équipe Labellisée Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France PubMed articlesGoogle scholar articles
  • Catherine Hill Bureau de Biostatistique et d’Épidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Dan Chaltiel; dan.chaltiel{at}gustaveroussy.fr
View Full Text

Citation

Chaltiel D, Hill C
Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why?

Publication history

  • Received October 27, 2020
  • Accepted May 10, 2021
  • First published June 22, 2021.
Online issue publication 
February 15, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.